Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 21(18): 5274-82, 2011 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-21803580

RESUMO

The Hedgehog (Hh-) signalling pathway is a key developmental pathway and there is a growing body of evidence showing that this pathway is aberrantly reactivated in a number of human tumors. Novel agents capable of inhibiting this pathway are sought, and an entirely novel series of smoothened (Smo) antagonists capable of inhibiting the pathway have been identified through uHTS screening. Extensive exploration of the scaffold identified the key functionalities necessary for potency, enabling potent nanomolar Smo antagonists like 91 and 94 to be developed. Optimization resulted in the most advanced compounds displaying low serum shift, clean off-targets profile, and moderate clearance in both rats and dogs. These compounds are valuable tools with which to probe the biology of the Hh-pathway.


Assuntos
Proteínas Hedgehog/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Ureia/farmacologia , Animais , Cães , Relação Dose-Resposta a Droga , Proteínas Hedgehog/metabolismo , Humanos , Microssomos/efeitos dos fármacos , Microssomos/metabolismo , Estrutura Molecular , Ratos , Estereoisomerismo , Relação Estrutura-Atividade , Ureia/análogos & derivados , Ureia/química
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa